Acciones BetterLife Pharma Inc. Other OTC
Acciones
BETRF
CA08772P2026
Biotecnología e investigación médica
Ventas 2023 | - | Ventas 2024 | - | Capitalización | 8,69 M 8,09 M |
---|---|---|---|---|---|
Resultado Neto 2023 | -9 M -8,38 M | Resultado Neto 2024 | -2 M -1,86 M | VE / Ventas 2023 | - |
Deuda neta 2023 | 71,69 mil 66,75 mil | Deuda neta 2024 | 290 mil 270 mil | VE / Ventas 2024 | - |
P/E ratio 2023 |
-1,36
x | P/E ratio 2024 |
-2,84
x | Empleados | - |
Rendimiento 2023 * |
-
| Rendimiento 2024 |
-
| Flotante | 72,88 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,34 % | 125 mil M | |
+15,06 % | 108 mil M | |
-6,39 % | 23,64 mil M | |
+2,39 % | 22,39 mil M | |
-12,11 % | 17,78 mil M | |
-41,64 % | 16,43 mil M | |
-12,07 % | 16,34 mil M | |
+1,05 % | 13,56 mil M | |
+25,87 % | 11,59 mil M |